Bayu Perkasa Rosari
Departemen Patologi Anatomi, Fakultas Kedokteran Dan Ilmu Kesehatan, Universitas Katolik Indonesia Atma Jaya

Published : 5 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 5 Documents
Search

Ketepatan Pemeriksaan Imunohistokimia CK19 Dibandingkan dengan PDX-1 pada Tumor Pankreas dan Anak Sebarnya Bayu Perkasa Rosari; Michelle Linggodigdo; Yan Cahya Wijaya; Marini Stephanie; Nur Rahadiani
Majalah Patologi Indonesia Vol 30 No 3 (2021): MPI
Publisher : Perhimpunan Dokter Spesialis Patologi Indonesia (IAPI)

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (529.31 KB) | DOI: 10.55816/mpi.v30i3.479

Abstract

BackgroundMetastatic adenocarcinoma of unknown origin remains a serious problem in oncology. Pancreatic cancer is often diagnosed when ithas already metastasized. Therefore immunohistochemistry (IHC) examination for detecting metastases of pancreatic origin is veryimportant IHC marker of Pancreatic duodenal homeobox-1 (PDX-1) has a good accuracy for detecting metastases of pancreaticorigin, however it is not readily available in many centers in Indonesia. Instead, IHC marker that is often being used is CK19. Thismarker is not specific, because it is also expressed by gastrointestinal and hepatobilliary tumors. This evidence-based case reportaims to determine the accuracy of CK19 compared with PDX-1 IHC for detecting pancreatic tumor and its metastases.MethodsLiterature searches were conducted on Pubmed/MEDLINE®, Scopus®, Cochrane®databases. Four articles about PDX-1 and 5 articlesabout CK19 that are relevant were found. Those articles were critically appraised.ResultsAll articles are considered valid, as they fulfilled the important criteria for journal validity. A study of CK19 IHC found that this markerhas 100% sensitivity and 6% specificity for diagnosing liver metastases from well-differentiated pancreatic ductal adenocarcinoma.Studies of PDX-1 IHC have different results; a study found that 27 out of 67 were PDX-1 positive in metastases of pancreaticadenocarcinoma origin, while another study found that PDX-1 has 72% sensitivity and 93% specificity for pancreatic neuroendocrinetumor, with 100% sensitivity and 75% specificity for pancreatic neuroendocrine tumor metastases.ConclusionCK19 IHC is highly sensitive for detecting adenocarcinoma metastases of pancreatic origin, thus it can be utilized as a screening test.However, CK19 IHC specificity for detecting adenocarcinoma metastases of pancreatic origin is low compared to PDX-1 IHC
Clinicopathological Characteristics of Cutaneous Melanocytic Lesions for Predicting Biological Behavior: 5 Years Retrospective Study in National Referral Hospital Rosari, Bayu Perkasa; Arisanty, Riesye
Majalah Patologi Indonesia Vol. 34 No. 1, Januari 2025
Publisher : Perhimpunan Dokter Spesialis Patologi Anatomik Indonesia (PDSPA)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55816/mpi.v34i1.648

Abstract

Background Cutaneous melanocytic lesions have variety of subtypes ranging from benign (nevus) to malignant lesions (malignant melanoma). Differentiating benign and malignant melanocytic lesions is challening, particularly due to overlapping characteristics. This study was conducted to determine clinicopathological characteristics of cutaneous melanocytic lesions and the prevalence ratio of each characteristic for predicting malignant behavior. Method Cross-sectional study was conducted with data retrieved from Anatomic Pathology Department of Faculty of Medicine Universitas Indonesia and Dr. Cipto Mangunkusumo Hospital. Data of 145 histopathology-confirmed cutaneous melanocytic lesions cases between 2018 – 2022 were sampled and collected. Bivariate analysis was used to determine the prevalence ratio of each characteristic to predict malignant behavior. Result Out of 145 cases, 14.5% were malignant lesions (melanoma) and the rest were benign (nevus). Clinicopathology features and characteristics were correlated with malignant behavior, such as cytological atypia (p <0.01), dermal mitosis (PR=91.5; p<0.01), asymmetry (PR=31.8; p <0.01), suprabasal melanocyte (PR=21.4; p <0.01), lower extremity location (PR=6.5; p <0.01), sized >6 mm (PR=5.2; p <0.01), and male gender (PR=3.3; p <0.01). Conclusion Clinicopathological characteristics of cutaneous melanocytic lesions such as cytological atypia, dermal mitosis, asymmetry, suprabasal melanocyte, lower extremity location, sized >6 mm, dermal lymphocytic infiltrate, and male gender were predictive to predict malignant lesions.
Ketepatan Pemeriksaan Imunohistokimia CK19 Dibandingkan dengan PDX-1 pada Tumor Pankreas dan Anak Sebarnya Rosari, Bayu Perkasa; Linggodigdo, Michelle; Wijaya, Yan Cahya; Stephanie, Marini; Nur Rahadiani
Majalah Patologi Indonesia Vol. 30 No. 3, September 2021
Publisher : Perhimpunan Dokter Spesialis Patologi Anatomik Indonesia (PDSPA)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55816/mpi.v30i3.479

Abstract

BackgroundMetastatic adenocarcinoma of unknown origin remains a serious problem in oncology. Pancreatic cancer is often diagnosed when ithas already metastasized. Therefore immunohistochemistry (IHC) examination for detecting metastases of pancreatic origin is veryimportant IHC marker of Pancreatic duodenal homeobox-1 (PDX-1) has a good accuracy for detecting metastases of pancreaticorigin, however it is not readily available in many centers in Indonesia. Instead, IHC marker that is often being used is CK19. Thismarker is not specific, because it is also expressed by gastrointestinal and hepatobilliary tumors. This evidence-based case reportaims to determine the accuracy of CK19 compared with PDX-1 IHC for detecting pancreatic tumor and its metastases.MethodsLiterature searches were conducted on Pubmed/MEDLINE®, Scopus®, Cochrane®databases. Four articles about PDX-1 and 5 articlesabout CK19 that are relevant were found. Those articles were critically appraised.ResultsAll articles are considered valid, as they fulfilled the important criteria for journal validity. A study of CK19 IHC found that this markerhas 100% sensitivity and 6% specificity for diagnosing liver metastases from well-differentiated pancreatic ductal adenocarcinoma.Studies of PDX-1 IHC have different results; a study found that 27 out of 67 were PDX-1 positive in metastases of pancreaticadenocarcinoma origin, while another study found that PDX-1 has 72% sensitivity and 93% specificity for pancreatic neuroendocrinetumor, with 100% sensitivity and 75% specificity for pancreatic neuroendocrine tumor metastases.ConclusionCK19 IHC is highly sensitive for detecting adenocarcinoma metastases of pancreatic origin, thus it can be utilized as a screening test.However, CK19 IHC specificity for detecting adenocarcinoma metastases of pancreatic origin is low compared to PDX-1 IHC
PENINGKATAN PENGETAHUAN KANKER PAYUDARA DAN SADARI (PEMERIKSAAN PAYUDARA SENDIRI) PADA PEREMPUAN DI CILINCING, JAKARTA UTARA Bayu Perkasa Rosari; Christian Ardianto; Safira Aurea; Sitara Kirana
Mitramas: Jurnal Pengabdian dan Pemberdayaan Masyarakat Vol. 4 No. 02 (2026): Mitramas, Jurnal Pengabdian dan Pemberdayaan Masyarakat
Publisher : Universitas Katolik Indonesia Atma Jaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.25170/mitramas.v4i02.7425

Abstract

Organisasi Kesehatan Dunia (World Health Organization/WHO) melaporkan bahwa pada tahun 2022 terdapat sekitar 1,3 juta kasus baru kanker payudara dan 670.000 kematian akibat penyakit tersebut. Di Indonesia, data GLOBOCAN tahun 2022 mencatat 66.271 kasus dengan 22.598 kematian. Salah satu upaya untuk mendeteksi gejala kanker payudara secara dini adalah dengan melakukan teknik SADARI (Pemeriksaan Payudara Sendiri). Survei Kesehatan Indonesia tahun 2023 melaporkan bahwa 87–95% perempuan usia reproduksi belum pernah melakukan SADARI. Rendahnya praktik ini disebabkan kurangnya informasi, minimnya dukungan keluarga, serta terbatasnya edukasi kesehatan. Edukasi masyarakat dilakukan melalui kegiatan penyuluhan dengan topik “Pencegahan dan Deteksi Dini Kanker Payudara.” Kegiatan diawali dengan pelaksanaan pre-test, dilanjutkan dengan sesi penyampaian materi, dan diakhiri dengan pengisian post-test oleh peserta. Kegiatan ditutup dengan pembagian konsumsi, suvenir, serta leaflet edukasi mengenai langkah-langkah SADARI dan SADANIS (Pemeriksaan Payudara Klinis). Kegiatan pendidikan dan pelatihan kesehatan mengenai deteksi dini kanker payudara melalui metode SADARI terbukti efektif dalam meningkatkan pengetahuan peserta tentang kanker payudara dan SADARI. Rata-rata skor peserta meningkat dari 54,23 pada pre-test menjadi 88,46 pada post-test, menunjukkan peningkatan sebesar 70,49%.  
PENINGKATAN PENGETAHUAN KANKER PAYUDARA DAN SADARI (PEMERIKSAAN PAYUDARA SENDIRI) PADA PEREMPUAN DI CILINCING, JAKARTA UTARA Bayu Perkasa Rosari; Christian Ardianto; Safira Aurea; Sitara Kirana
Mitramas: Jurnal Pengabdian dan Pemberdayaan Masyarakat Vol. 4 No. 02 (2026): Mitramas, Jurnal Pengabdian dan Pemberdayaan Masyarakat
Publisher : Universitas Katolik Indonesia Atma Jaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.25170/mitramas.v4i02.7425

Abstract

Organisasi Kesehatan Dunia (World Health Organization/WHO) melaporkan bahwa pada tahun 2022 terdapat sekitar 1,3 juta kasus baru kanker payudara dan 670.000 kematian akibat penyakit tersebut. Di Indonesia, data GLOBOCAN tahun 2022 mencatat 66.271 kasus dengan 22.598 kematian. Salah satu upaya untuk mendeteksi gejala kanker payudara secara dini adalah dengan melakukan teknik SADARI (Pemeriksaan Payudara Sendiri). Survei Kesehatan Indonesia tahun 2023 melaporkan bahwa 87–95% perempuan usia reproduksi belum pernah melakukan SADARI. Rendahnya praktik ini disebabkan kurangnya informasi, minimnya dukungan keluarga, serta terbatasnya edukasi kesehatan. Edukasi masyarakat dilakukan melalui kegiatan penyuluhan dengan topik “Pencegahan dan Deteksi Dini Kanker Payudara.” Kegiatan diawali dengan pelaksanaan pre-test, dilanjutkan dengan sesi penyampaian materi, dan diakhiri dengan pengisian post-test oleh peserta. Kegiatan ditutup dengan pembagian konsumsi, suvenir, serta leaflet edukasi mengenai langkah-langkah SADARI dan SADANIS (Pemeriksaan Payudara Klinis). Kegiatan pendidikan dan pelatihan kesehatan mengenai deteksi dini kanker payudara melalui metode SADARI terbukti efektif dalam meningkatkan pengetahuan peserta tentang kanker payudara dan SADARI. Rata-rata skor peserta meningkat dari 54,23 pada pre-test menjadi 88,46 pada post-test, menunjukkan peningkatan sebesar 70,49%.